The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling

Journal of Steroid Biochemistry and Molecular Biology

Volumn 65, Issue 1-6, 1998, Pages 65-74

  Desvergne, Béatrice ^a   Ijpenberg, Annemieke ^a   Devchand, Pallavi R ^a   Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; FATTY ACID; ICOSANOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEROID RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR;

ADIPOCYTE; CONFERENCE PAPER; DIET; FATTY ACID OXIDATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIGAND BINDING; LIPID STORAGE; NONHUMAN; PEROXISOME; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; XENOPUS LAEVIS;

CELL COMMUNICATION; DIET; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HORMONES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIGANDS; LIVER; MODELS, BIOLOGICAL; PITUITARY-ADRENAL SYSTEM; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS;

XENOPUS LAEVIS;

EID: 0032052816     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00182-9     Document Type: Conference Paper

References (48)

1. Vaulont S., Kahn A. Transcriptional control of metabolic regulation genes by carbohydrates. FASEB J. 8:1994;28-35.
2. Girard J., Perdereau D., Foufelle F., Prip-Buus C., Ferré P. Regulation of lipogenic enzyme expression by nutrients and hormones. FASEB J. 8:1994;36-42.
3. Desvergne, B. and Wahli, W. PPAR: A key nuclear factor in nutrient/gene interactions? In Inducible Gene Expression, Vol. 1, ed. P. A. Baeuerle. Birkhäuser, Boston, 1995, pp. 142-176.
4. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
5. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68:1992;879-887.
6. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor- retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA. 90:1993;2160-2164.
7. Göttlicher M., Widmark E., Li Q., Gustafsson J.-A. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 89:1992;4653-4657.
8. Wahli W., Braissant O., Desvergne B. Peroxisome proliferator activated receptors: Transcriptional regulators of adipogenesis, lipid metabolism and more. Chem. Biol. 2:1995;261-266.
9. Kliewer S. A., Forman B. M., Blumberg B., Ong E. S., Borgmeyer U., Mangelsdorf D. J., Umesono K., Evans R. M. Differential expression and activation of family murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA. 91:1994;7355-7359.
10. Schmidt A., Endo N., Rutledge S. J., Vogel R., Shinar D., Rodan G. A. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol. 6:1992;1634-1641.
11. Sher T., Yi H. F., Mcbride O. W., Gonzalez F. J. cDNA cloning, chromosomal mapping and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry. 32:1993;5598-5604.
12. Mukherjee R., Jow L., Croston G. E., Paterniti J. R. Jr. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 vs PPARγ1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 272:1997;8071-8076.
13. Braissant O., Foufelle F., Scotto C., Dauça M., Wahli W. Differential expression of peroxisome proliferator-activated receptors: Tissue distribution of PPAR-α, -β and -γ in the adult rat. Endocrinology. 137:1996;354-366.
14. Lemberger T., Braissant O., Juge-Aubry C., Keller H., Saladin R., Staels B., Auwerx J., Burger A. G., Meier C. A., Wahli W. PPAR tissue distribution and interactions with other hormone-signaling pathways. Ann. N. Y. Acad. Sci. 804:1996;231-251.
15. Norum, K. R., Christiansen, E. N., Christophersen, B. O. and Bremer, J., Metabolic and nutritional aspects of long chain fatty acids of marine origin. In The Role of Fat in Human Nutrition, eds. A. J. Vergroesen, M. Crawford. Academic Press, London, 1989, pp. 117-149.
16. Flatmark, T. and Christiansen E. N., Modulation of peroxisomal biogenesis and lipid metabolizing enzymes by dietary factors. In Peroxisomes: Biology and Importance in Toxicology and Medicine, eds. G. Gibson and B. Lake. Taylor, Francis, London, 1993, pp. 247-275.
17. Orellana M., Fuentes O., Rosenbluth H., Lara M., Valdez E. Modulation of rat liver peroxisomal and microsomal fatty acid oxidation by starvation. FEBS Lett. 310:1992;193-196.
18. Hori S., Ishii H., Suga T. Changes in peroxisomal fatty acid oxidation in diabetic rat liver. J. Biochem. 90:1981;1691-1696.
19. Lee S. S. T., Pineau T., Drago J., Lee E. J., Owens J. W., Kroetz D. L., Fernandez-Salguero P. M., Westphal H., Gonzalez F. J. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:1995;3012-3022.
20. Spiegelman B. M., Flier J. S. Adipogenesis and obesity: Rounding out the big picture. Cell. 87:1996;377-389.
21. Devchand P. R., Keller H., Peters J. M., Vazquez M., Gonzalez F. J., Wahli W. The PPARα-leukotriene B4 pathway to inflammation control. Nature. 384:1996;39-43.
22. Kliewer S. A., Lenhard J. M., Willson T. M., Patel I., Morris D. C., Lehmann J. M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor g and promotes adipocyte differentiation. Cell. 83:1995;813-819.
23. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M. 15-deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ Cell. 83:1995;803-812.
24. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A. An antidiabetic thiazolidinedione is a high affinity ligand for the nuclear receptor PPARγ J. Biol. Chem. 270:1995;12953-12956.
25. Dowell P., Peterson V. J., Zabriskie T. M., Leid M. Ligand-induced peroxisome proliferator-activated receptor α conformational change. J. Biol. Chem. 272:1997;2013-2020.
26. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M. G., Wahli W. Fatty acids, eicosanoids and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by CARLA. Mol. Endocrinol. 11:1997;779-791.
27. Forman B. M., Chen J., Evans R. M. Hypolipidemic drugs, polyunsaturated fatty acids and eicosanoids are ligands for PPARα and PPARδ Proc. Natl. Acad. Sci. USA. 94:1997;4312-4317.
28. Kliewer S. A., Sundseth S. S., Jones S. A., Brown P. J., Wisely G. B., Koble C. S., Devchand P., Wahli W., Willson T. M., Lenhard J. M., Lehmann J. M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proc. Natl. Acad. Sci. USA. 94:1997;4318-4323.
29. Onate, S. A., Tsai, S. Y., Tsai, M-J. and O'Malley, B. W., Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science, 1995, 270, 1354-1357.
30. Furstenberger G., Hagedorn H., Jacobi T., Besemfelder E., Stephan M., Lehman W. D., Marks F. Characterization of an 8-lipoxygenase activity induced by the phorbol ester tumor promoter 12-0-tetradecanoylphorbol-13-acetate in mouse skin in vivo. J. Biol. Chem. 266:1991;15738-15745.
31. Juge-Aubry C. E., Gorlabajszczak A., Pernin A., Lemberger T., Wahli W., Burger A. G., Meier C. A. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor: Possible role of a leucine zipper-like heptad repeat. J. Biol. Chem. 270:1995;18117-18122.
32. Keller H., Givel F., Perroud M., Wahli W. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol. Endocrinol. 9:1995;794-804.
33. Lemberger T., Staels B., Saladin R., Desvergne B., Auwerx J., Wahli W. Regulation of the peroxisome proliferator-activated receptor α gene by glucocorticoids. J. Biol. Chem. 269:1994;24527-24530.
34. Lemberger T., Saladin R., Vazquez M., Assimacopoulos F., Staels B., Desvergne B., Wahli W., Auwerx J. Expression of the peroxisome proliferator-activated receptor α gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem. 271:1996;1764-1769.
35. Kliewer S. A., Umesono K., Noonan D. J., Heyman R. A., Evans R. M. Convergence of 9-cis-retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 358:1992;771-774.
36. Mukherjee R., Davies P. J. A., Cromble D. L., Bischoff E. D., Cesario R. M., Jow L., Hamann L. G., Boehm M. F., Mondon C. E., Nadzan A. M., Paterniti J. R. Jr., Heyman R. A. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature. 386:1997;407-410.
37. Tugwood J. D., Issemann I., Anderson R. G., Bundell K. R., McPheat W. L., Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11:1992;433-439.
38. Nakshatri H., Chambon P. The directly repeated RG(G/T)TCA motifs of the rat and mouse cellular retinol-binding protein II genes are promiscuous binding sites for RAR, RXR, HNF-4 and ARP-1 homo- and heterodimers. J. Biol. Chem. 269:1994;890-902.
39. IJpenberg, A., Jeannin, E., Wahli, W. and Desvergne, B., Polarity and specific sequence requirements of PPAR-RXR heterodimer binding to DNA: A functional analysis of the malic enzyme gene PPRE. J. Biol. Chem., 1997, in press.
40. Juge-Aubry, C., Pernin, A., Favez, T., Burger, A. G., Wahli, W., Meier, C. A. and Desvergne, B., DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements: Importance of the 5′ flanking region. J. Biol. Chem., 1997, in revision.
41. Kurokawa R., Soderstrom M., Horlein A., Halachmi S., Brown M., Rosenfeld M. G., Glass C. K. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature. 377:1995;451-454.
42. Kurokawa R., DiRenzo J., Boehm M., Sugarman J., Gloss B., Rosenfeld M. G., Heyman R. A., Glass C. K. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature. 371:1994;528-531.
43. Forman B. M., Umesono K., Chen J., Evans R. M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 81:1995;541-550.
44. Perlmann T., Rangara P. N., Umesono K., Evans R. M. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev. 7:1993;1411-1422.
45. Kurokawa R., Yu V. C., Näär A., Kyakumoto S., Han Z., Silverman S., Rosenfeld M. G., Glass C. K. Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev. 7:1993;1423-1435.
46. Zechel C., Shen X.-Q., Chen J.-Y., Chen Z.-P., Chambon P., Gronmeyer H. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J. 13:1994;1425-1433.
47. Glass C. K. Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocrine Rev. 15:1994;391-407.
48. Palmer C. N. A., Hsu M.-H., Griffin K. J., Johnson E. F. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270:1995;16114-16121.